ACTRN12611000344998尚未招募3 期
Comparative Multicentre trial assessing the incidence of urinary tract infections using the conventional silicone catheter with a stainless steel catheter for intermittent self catheterising in patients who have a neurogenic bladder and a post void residual volume of >100mls
Dr LJ (Vic) du Plessis0 个研究点目标入组 50 人开始时间: 2011年4月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 16 Years 至 75 Years（—）
- 性别
- Female
入选标准
- •(1) Female patients aged 16 - 75.
- •(2) The patient must have a neurogenic bladder and a post void residual volume > 100mls.
- •(3) The patient must be able to self-catheterise without assistance from a carer.
- •(4) There must be a history of recurrent urinary tract infections associated with self-catheterisation.
排除标准
- •(1) History of urethral trauma/stricture.
- •(2) Inadequate upper limb dexterity to be able to self-catheterise.
- •(3) No history of infections in the preceding 14 days.
研究者
相似试验
招募中
不适用
Multicenter comparative study to examine the efficacy of zoledronic acid in prostate cancer with bone metastasis at different hormone sensitivity status.JPRN-UMIN000002792Tama Prostate cancer Bone metastasis Study group200
进行中（未招募）
不适用
A multicentre randomised trial comparing the effects of 2% chlorhexidine gluconate in 70% isopropyl alcohol as a skin, exit site and catheter hub cleansing agent versus other forms of chlorhexidine gluconate which are in routine use, on central venous catheter-related infections in haemodialysis patientsPrevention of central venous catheter-related infections in haemodialysis patients.This trial will evaluate the effectiveness of 2% chlorhexidine gluconate in 70%isopropyl alcohol as a skin, exit site and catheter hub cleansing agent in the reduction of CVC-related infections in haemodialysis patients, in comparison to the other forms of chlorhexidine gluconate that are in routine use in dialysis centres in Ireland.EUCTR2010-019984-12-IEAdelaide & Meath Hospital, incorporating The National Children's Hospital180
进行中（未招募）
1 期
A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus placebo vs. pegylated interfeorn-alfa-2a plus tenofovir for the treatment of chronic delta hepatitis- The Hep-Net International Delta hepatits Interventional Trial II (HIDIT-II) - HIDIT-IITo compare the virological efficacy (HDV-RNA) and safety of 96 weeks of therapy with pegylated interferon-alfa-2a plus tenovofir to 96 weeks of therapy with pegylated interferon-alfa-2a plus placebo for the treatment with chronic delta hepatits virus.MedDRA version: 9.1Level: LLTClassification code 10047455Term: Viral hepatitis B without mention of hepatic coma, with hepatitis deltaEUCTR2008-005560-13-GRMedizinische Hochschule Hannover70
已完成
不适用
A multicenter randomised study comparing the efficacy of adefovir dipivoxil versus pegylated interferon alpha-2a plus placebo versus adefovir dipivoxil plus peglyated interferon alpha-2a for the treatment of chronic delta hepatitisAdults with chronic delta hepatitisInfections and InfestationsISRCTN83587695Hannover Medical School (MHH) (Germany)69
进行中（未招募）
1 期
Treatment of delta hepatitis with pegylated interferon-alfa-2a and tenofovir or placeboTo compare the virological efficacy (HDV-RNA) and safety of 96 weeks of therapy with pegylated interferon-alfa-2a plus tenovofir to 96 weeks of therapy with pegylated interferon-alfa-2a plus placebo for the treatment with chronic delta hepatits virus.MedDRA version: 15.1Level: LLTClassification code 10047455Term: Viral hepatitis B without mention of hepatic coma, with hepatitis deltaSystem Organ Class: 100000004862EUCTR2008-005560-13-DEMedizinische Hochschule Hannover70